Nosratollah Zarghami Selected Research

Nosratollah Zarghami Research Topics

Disease

86	Neoplasms (Cancer) 10/2022 - 10/2008
31	Breast Neoplasms (Breast Cancer) 10/2022 - 12/2012
15	Lung Neoplasms (Lung Cancer) 02/2022 - 01/2014
8	Obesity 04/2022 - 01/2009
8	Neoplasm Metastasis (Metastasis) 02/2021 - 01/2017
7	Inflammation (Inflammations) 04/2022 - 09/2016
7	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2009
7	Stomach Neoplasms (Stomach Cancer) 10/2017 - 01/2013
6	Insulin Resistance 04/2022 - 06/2011
6	Carcinogenesis 01/2020 - 12/2012
5	Ovarian Neoplasms (Ovarian Cancer) 06/2022 - 12/2018
4	Leukemia 07/2022 - 11/2015
4	Carcinoma (Carcinomatosis) 12/2019 - 09/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2016
4	Colorectal Neoplasms (Colorectal Cancer) 06/2018 - 12/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 04/2018 - 10/2008
4	Diabetes Mellitus 01/2018 - 09/2016
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2018
3	Necrosis 01/2018 - 01/2017
3	Infarction (Infarctions) 01/2018 - 01/2017
3	Oligospermia (Oligozoospermia) 01/2008 - 06/2007
3	Asthenozoospermia 01/2008 - 06/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 01/2014
2	Retinoblastoma (Glioblastoma, Retinal) 10/2021 - 07/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2014
2	Wounds and Injuries (Trauma) 01/2021 - 02/2018
2	Drug-Related Side Effects and Adverse Reactions 12/2018 - 01/2013
2	Infections 01/2018 - 11/2017
2	Ischemia 01/2018 - 03/2017

Drug/Important Bio-Agent (IBA)

21	MicroRNAs (MicroRNA)IBA 07/2022 - 02/2014
20	Pharmaceutical PreparationsIBA 03/2022 - 12/2012
18	chrysinIBA 03/2022 - 01/2015
17	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 01/2013
16	CurcuminIBA 01/2022 - 01/2013
12	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2013
12	Proteins (Proteins, Gene)FDA Link 02/2021 - 06/2011
10	Metformin (Glucophage)FDA LinkGeneric 10/2022 - 01/2018
10	Silybin (Lagosa)IBA 03/2022 - 12/2012
7	Biological ProductsIBA 08/2021 - 06/2011
7	AdipokinesIBA 01/2018 - 01/2013
6	Hormones (Hormone)IBA 01/2021 - 10/2008
5	Cyclin D1IBA 10/2022 - 01/2017
5	LeptinIBA 02/2022 - 10/2008
5	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2012
4	PolymersIBA 03/2022 - 09/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2016
4	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 06/2007
4	ErbB Receptors (EGF Receptor)IBA 08/2020 - 11/2016
4	AntioxidantsIBA 06/2018 - 06/2007
4	flavoneIBA 06/2018 - 08/2016
4	Insulin (Novolin)FDA Link 01/2018 - 01/2015
4	VaccinesIBA 04/2016 - 12/2015
3	Caspase 3 (Caspase-3)IBA 10/2022 - 01/2020
3	PhytochemicalsIBA 10/2022 - 01/2016
3	CarbonIBA 03/2022 - 03/2020
3	CyclodextrinsIBA 01/2022 - 01/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2018
3	NF-kappa B (NF-kB)IBA 10/2021 - 01/2014
3	LigandsIBA 10/2021 - 01/2016
3	FlavonoidsIBA 08/2021 - 01/2013
3	CoagulaseIBA 02/2021 - 01/2017
3	AntibodiesIBA 08/2020 - 11/2016
3	CytokinesIBA 12/2018 - 01/2018
3	EnzymesIBA 10/2018 - 01/2016
3	Genetic Markers (Genetic Marker)IBA 04/2018 - 01/2014
3	Nicotinamide PhosphoribosyltransferaseIBA 01/2018 - 01/2013
3	ResistinIBA 12/2017 - 01/2013
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017 - 01/2016
3	Angiogenesis InhibitorsIBA 03/2017 - 06/2016
3	8-epi-prostaglandin F2alphaIBA 01/2008 - 06/2007
2	Caspase 7IBA 10/2022 - 08/2021
2	artemisinin (artemisinine)IBA 10/2022 - 03/2022
2	SurvivinIBA 10/2022 - 08/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 07/2021
2	PolyphenolsIBA 01/2022 - 01/2021
2	Dendrimers (Dendrons)IBA 10/2021 - 01/2013
2	Ciliary Neurotrophic Factor (CNTF)IBA 07/2021 - 12/2018
2	Therapeutic UsesIBA 07/2021 - 04/2017
2	vadimezanIBA 02/2021 - 01/2018
2	QuercetinIBA 01/2021 - 01/2016
2	Plant ExtractsIBA 01/2021 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 10/2018
2	Immunoglobulin G (IgG)IBA 08/2020 - 04/2016
2	Metalloproteases (Metalloproteinases)IBA 12/2018 - 04/2017
2	Immunotoxins (Immunotoxin)IBA 12/2018 - 01/2017
2	BiguanidesIBA 11/2018 - 12/2017
2	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 09/2018 - 06/2018
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2018 - 10/2017
2	Oxygen (Dioxygen)IBA 02/2018 - 03/2017
2	HydrogelsIBA 02/2018 - 01/2016
2	AndrogensIBA 01/2018 - 01/2015
2	ApelinIBA 01/2018 - 12/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 12/2017

Therapy/Procedure

46	Therapeutics 10/2022 - 12/2012
10	Drug Therapy (Chemotherapy) 03/2022 - 01/2016
3	Aftercare (After-Treatment) 06/2018 - 04/2017
3	Immunotherapy 04/2016 - 12/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 02/2014